November/December 2012 | Treatment Of Retinoblastoma In The First 3 Months Of Life: Bridge Therapy
Treatment of Retinoblastoma in the First 3 Months of Life: Bridge Therapy
David H. Abramson, MD, FACS
October 28, 2020
Norlase Announces FDA Clearance and U.S. Launch of New LION Laser System
Allergan Announces Positive Phase 3 Topline Results for Investigational Eye Drop for the Treatment of Presbyopia
October 27, 2020
CVS Pharmacy Launches QuickRenew At-Home Contact Lens Prescription Renewal Tool
AstraZeneca’s COVID-19 Vaccine Produces Robust Immune Response in Elderly
October 2020 Insert
Sponsored By Bausch + Lomb
October 2020 Supplement
This activity is supported by an unrestricted educational grant from Allergan.
This activity is supported by supported by an unrestricted educational grant from Regeneron Pharmaceuticals.
Free Print Subscription